Journal for ImmunoTherapy of Cancer (Nov 2020)
714 PD1 x TGFβR2 bispecifics selectively block TGFβR2 on PD1-positive T cells, promote T cell activation, and elicit an anti-tumor response in solid tumors
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2020)